Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05020236
PHASE3

A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments

Sponsor: Pfizer

View on ClinicalTrials.gov

Summary

The purpose of this clinical trial is to (1) learn whether the BCMA-CD3 bispecific antibody elranatamab can provide more benefit to people with multiple myeloma compared to a combination therapy including daratumumab, pomalidomide, and dexamethasone, and (2) learn about the safety and activity of elranatamab in combination with the anti-CD38 monoclonal antibody daratumumab. People with multiple myeloma who have received previous treatment including lenalidomide will be enrolled in the study. Part 1 of the study will assess the safety and activity of different doses of elranatamab in combination with daratumumab. People participating in Part 2 of the study will be randomly assigned to receive either elranatamab alone, elranatamab plus daratumumab, or daratumumab, pomalidomide, and dexamethasone. Part 2 will evaluate the safety and activity of (1) elranatamab alone compared to daratumumab, pomalidomide, and dexamethasone, and (2) elranatamab plus daratumumab. Part 3 will assess the effect of increased measures to protect against infection in people treated with either elranatamab alone or together with daratumumab. All people participating in the study will receive study treatment until their disease progresses, they experience unacceptable side effects, or they choose to no longer participate in the study.

Official title: AN OPEN-LABEL, 3-ARM, MULTICENTER, RANDOMIZED PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ELRANATAMAB (PF-06863135) MONOTHERAPY AND ELRANATAMAB + DARATUMUMAB VERSUS DARATUMUMAB + POMALIDOMIDE + DEXAMETHASONE IN PARTICIPANTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA WHO HAVE RECEIVED AT LEAST 1 PRIOR LINE OF THERAPY INCLUDING LENALIDOMIDE AND A PROTEASOME INHIBITOR

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

944

Start Date

2021-10-04

Completion Date

2027-05-31

Last Updated

2026-05-05

Healthy Volunteers

No

Interventions

DRUG

Elranatamab

subcutaneous

DRUG

Daratumumab

Daratumumab / hyaluronidase, subcutaneous

DRUG

Pomalidomide

oral

DRUG

Dexamethasone

oral

Locations (90)

Clovis Community Medical Center

Clovis, California, United States

Community Regional Medical Center

Fresno, California, United States

UCHealth Poudre Valley Hospital

Fort Collins, Colorado, United States

UCHealth Greeley Hospital

Greeley, Colorado, United States

Sylvester Comprehensive Cancer Center - Aventura

Aventura, Florida, United States

Sylvester Comprehensive Cancer Center - Coral Springs

Coral Springs, Florida, United States

University of Miami Hospital and Clinics - Deerfield Beach

Deerfield Beach, Florida, United States

Sylvester Comprehensive Cancer Center - Hollywood

Hollywood, Florida, United States

University of Miami Hospital and Clinics

Miami, Florida, United States

Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street).

New York, New York, United States

Memorial Sloan Kettering Cancer Center - Main Campus

New York, New York, United States

Hospital Universitario Austral

Presidente Derqui, Buenos Aires, Argentina

Pindara Private Hospital

Benowa, Queensland, Australia

QScan Radiology Clinics

Clayfield, Queensland, Australia

Gallipoli Medical Research Foundation

Greenslopes, Queensland, Australia

Slade Pharmacy

Richmond, Victoria, Australia

Linear Clinical Research

Perth, Western Australia, Australia

Instituto D'Or de Pesquisa e Ensino (IDOR) - Filial Salvador

Salvador, Estado de Bahia, Brazil

Centro Gaucho Integrado De Oncologia, Hematologia, Ensino E Pesquisa

Porto Alegre, Rio Grande do Sul, Brazil

Hospital Mae de Deus

Porto Alegre, Rio Grande do Sul, Brazil

Clínica Médica São Germano LTDA

SP, São Paulo, Brazil

Instituto de Educação, Pesquisa e Gestão em Saúde

Rio de Janeiro, Brazil

HU UNIFESP / SPDM - Hospital São Paulo

São Paulo, Brazil

Clínica Médica São Germano S/S Ltda

São Paulo, Brazil

Instituto D'Or de Pesquisa e Ensino (IDOR)

São Paulo, Brazil

Instituto D'Or de Pesquisa e Ensino (IDOR)

São Paulo, Brazil

CIUSSS de l'Est-de-l'Île-de-Montréal

Montreal, Quebec, Canada

Saskatoon Cancer Center

Saskatoon, Saskatchewan, Canada

Fujian Medical University Union Hospital

Fuzhou, Fujian, China

Nanfang Hospital of Southern Medical University

Guangzhou, Guangdong, China

Sun Yat-sen University Cancer Center

Guangzhou, Guangdong, China

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

Wuhan, Hubei, China

Nanjing Drum Tower Hospital , The Affiliated Hospital of Nanjing University Medical School

Nanjing, Jiangsu, China

The Affiliated Hospital of Xuzhou Medical University

Xuzhou, Jiangsu, China

Shandong Provincial Hospital

Jinan, Shandong, China

Institute of hematology&blood disease hospital

Tianjin, Tianjin Municipality, China

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences

Beijing, China

Chongqing University Cancer Hospital

Chongqing, China

Fakultní nemocnice Brno Bohunice

Brno, Brno-m?sto, Czechia

Fakultni Nemocnice Plzen

Plzen - Lochotin, Plzeň Region, Czechia

Fakultni poliklinika

Prague, Praha 2, Czechia

Helsinki University Hospital - Comprehensive Cancer Center (HYKS - Syöpäkeskus)

Helsinki, Finland

Centre Hospitalier Universitaire de Limoges - Hôpital Dupuytren

Limoges, Limousin, France

Hôpital Saint Antoine

Paris, France

Centre Hospitalier Lyon Sud - Service d'Hematologie Clinique

Pierre-Bénite, France

Charité Universitätsmedizin Berlin

Berlin, Germany

Universitätsklinikum rechts der Isar, Technische Universität München (TUM)

München, Germany

Alexandra General Hospital of Athens

Athens, Attikí, Greece

Theageneio Cancer Hospital of Thessaloniki

Thessaloniki, Kentrikí Makedonía, Greece

Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico

Milan, Lombardy, Italy

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola

Bologna, Italy

National Hospital Organization Shibukawa Medical Center

Shibukawa, Gunma, Japan

Tohoku University Hospital

Sendai, Miyagi, Japan

Akita University Hospital

Akita, Japan

National Hospital Organization Kumamoto Medical Center

Kumamoto, Japan

Nagasaki University Hospital

Nagasaki, Japan

National Hospital Organization Okayama Medical Center

Okayama, Japan

Yamagata University Hospital

Yamagata, Japan

Hospital Universitario "Dr. Jose Eleuterio Gonzalez"

Monterrey, Nuevo León, Mexico

North Shore Hospital

Auckland, New Zealand

Labtests Auckland Ltd.

Auckland, New Zealand

Aotearoa Clinical Trials

Auckland, New Zealand

Waikato District Health Board, Waikato Hospital

Hamilton, New Zealand

Palmerston North Hospital

Roslyn, New Zealand

Oslo Universitetssykehus Ullevål

Oslo, Norway

St Olavs Hospital

Trondheim, Norway

Szpital Uniwersytecki nr 2 im. dr Jana Biziela w Bydgoszczy Klinika Hematologii

Bydgoszcz, Poland

Uniwersytecki Szpital Kliniczny w Poznaniu

Poznan, Poland

Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wroclawiu

Wroclaw, Poland

Institut Català d'Oncologia - L'Hospitalet

L'Hospitalet Del Llobregat, Barcelona [barcelona], Spain

Hospital Universitari Mutua Terrassa

Terrassa, Barcelona, Spain

Clinica Universidad de Navarra

Pamplona, Navarre, Spain

Hospital Universitario de Toledo

Toledo, Other, Spain

Hospital Universitari Vall d'Hebron

Barcelona, Spain

Hospital Universitari De Girona Doctor Josep Trueta

Girona, Spain

Hospital Universitario La Princesa

Madrid, Spain

Hospital Universitario Madrid Sanchinarro

Madrid, Spain

Hospital Universitario de Salamanca

Salamanca, Spain

Hospital Universitario Virgen Del Rocio

Seville, Spain

Skånes Universitetssjukhus Lund

Lund, Skåne LÄN [se-12], Sweden

Falu Lasarett

Falun, Sweden

Sahlgrenska Universitetssjukhuset

Gothenburg, Sweden

Universitetssjukhuset Örebro

Örebro, Örebro LÄN [se-18], Sweden

China Medical University Hospital

Taichung, Taiwan

National Cheng Kung University Hospital

Tainan, Taiwan

National Taiwan University Hospital

Taipei, Taiwan

Ege Universitesi Hastanesi

Izmir, İ̇zmir, Turkey (Türkiye)

Dokuz Eylul Universitesi Hastanesi

Izmir, İ̇zmir, Turkey (Türkiye)

Akdeniz Universitesi Hastanesi

Antalya, Turkey (Türkiye)

University Hospital of Wales

Cardiff, South Glamorgan, United Kingdom